Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin

scientific article published on 5 March 2011

Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.FERTNSTERT.2011.02.013
P698PubMed publication ID21377153

P50authorClaus Yding AndersenQ43119777
Peter HumaidanQ54217726
P2093author name stringAnne Lis Mikkelsen
Misao Fukuda
Lars Grabow Westergaard
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)2034-2038
P577publication date2011-03-05
P1433published inFertility and SterilityQ15724525
P1476titleLevels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin
P478volume95

Reverse relations

cites work (P2860)
Q34875744A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
Q48647282Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols
Q41545744Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial
Q36321457Decorin is a part of the ovarian extracellular matrix in primates and may act as a signaling molecule
Q48616560Developmental competence of oocytes isolated from surplus medulla tissue in connection with cryopreservation of ovarian tissue for fertility preservation
Q48529176Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles
Q38495382Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
Q55116047Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study.
Q35112937GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells
Q41011753GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
Q24193015Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
Q49444774Hallmarks of Human Small Antral Follicle Development: Implications for Regulation of Ovarian Steroidogenesis and Selection of the Dominant Follicle
Q35989750Identification of Differentially Expressed Genes Associated with Litter Size in Berkshire Pig Placenta
Q46174952In vitro maturation of oocytes alters gene expression and signaling pathways in bovine cumulus cells
Q38368170Oocyte maturation: gamete-somatic cells interactions, meiotic resumption, cytoskeletal dynamics and cytoplasmic reorganization.
Q48511028Significance of epidermal growth factor receptor signaling for acquisition of meiotic and developmental competence in mammalian oocytes
Q48641180Specific genes are selectively expressed between cumulus and granulosa cells from individual human pre-ovulatory follicles
Q48653020The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation

Search more.